← All organizations

Constellation Pharmaceuticals

For profitWebsite ↗

Also known as: Constellation Pharmaceuticals

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 13, 2024

Acquired by MorphoSys → Novartis on Jun 3, 2021

Timeline

2000s

Jun 1, 2008
Constellation Pharmaceuticals— Founded

2020s

Jun 3, 2021
MorphoSys— Acquired By
Feb 6, 2024
Novartis— Now

Drugs by trial phase (9 distinct, 10 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (7 own, 0 via acquisition)

Indications

Studied for

Recent trials (16)

NCT06401356Lead sponsorPhase 3Aug 13, 2024
NCT05391022Lead sponsorPhase 1Jul 26, 2021
NCT04603495Lead sponsorPhase 3Nov 19, 2020
NCT04104776Lead sponsorPhase 1/Phase 2Sep 18, 2019
NCT03525795Lead sponsorPhase 1/Phase 2Dec 14, 2017
NCT03525795Study directorPhase 1/Phase 2Dec 14, 2017
NCT03480646Lead sponsorPhase 1/Phase 2Nov 15, 2017
NCT03480646Study directorPhase 1/Phase 2Nov 15, 2017
NCT02395601Lead sponsorPhase 1Mar 1, 2015
NCT02395601Study directorPhase 1Mar 1, 2015
NCT02157636Study directorPhase 1Jul 1, 2014
NCT02157636Lead sponsorPhase 1Jul 1, 2014
NCT02158858Study directorPhase 1Jun 1, 2014
NCT02158858Lead sponsorPhase 1Jun 1, 2014
NCT01949883Lead sponsorPhase 1Sep 1, 2013

Details

Founded: Cambridge, MA, US Jun 1, 2008
Last known activity: Aug 13, 2024